Ja Sterile Profile
Key Indicators
- Authorised Capital ₹ 4.90 Cr
as on 04-12-2024
- Paid Up Capital ₹ 4.88 Cr
as on 04-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.02 Cr
as on 04-12-2024
- Revenue 14435.08%
(FY 2022)
- Profit -198.26%
(FY 2022)
- Ebitda 543.17%
(FY 2022)
- Net Worth -52.54%
(FY 2022)
- Total Assets 10.59%
(FY 2022)
About Ja Sterile
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.90 Cr and a paid-up capital of Rs 4.88 Cr.
The company currently has active open charges totaling ₹26.02 Cr.
Bharat Mehta, Hitendra Mehta, Kirti Mehta, and Six other members serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PTC101210
- Company No.
101210
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ja Sterile?
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhav Mehta  | Director | 12-Feb-2024 | Current |
| Bharat Mehta | Director | 12-Feb-2024 | Current |
| Hitendra Mehta | Director | 12-Feb-2024 | Current |
| Kirti Mehta | Director | 12-Feb-2024 | Current |
| Dineshkumar Chaudhari | Director | 12-Mar-2018 | Current |
| Vaghajibhai Chaudhari | Director | 20-May-2024 | Current |
Financial Performance and Corporate Structure Insights of Ja Sterile.
Ja Sterile Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14435.08% increase. The company also saw a substantial fall in profitability, with a 198.26% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ja Sterile?
In 2022, Ja Sterile had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oceanic Techno Chem Private LimitedActive 28 years 9 monthsBharat Mehta, Hitendra Mehta and 1 more are mutual person
- Aquatic Formulations (India) LimitedActive 25 years 14 days
Bharat Mehta, Hitendra Mehta and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 23 Oct 2024 | ₹2.42 Cr | Open |
Sidbi Creation Date: 19 Mar 2021 | ₹2.80 Cr | Open |
Sidbi Creation Date: 20 Dec 2019 | ₹10.40 Cr | Open |
How Many Employees Work at Ja Sterile?
Ja Sterile has a workforce of 48 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ja Sterile, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ja Sterile's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
